How The Integration Of Emerging Quantum And AI Technologies Can Impact Precision Medicine

We are living in a transformative era for life sciences. Advances in next-generation sequencing have enabled clinicians to detect genetic variants at a greater scale. Yet despite this progress, in my experience, the ability to interpret these variants and translate them into actionable clinical insights remains one of the most significant bottlenecks in precision medicine.​

Understanding the clinical significance of genetic variants detected through genomic approaches is a foundational element of modern medicine, particularly as, from my observations, a more ​proactive, genomics-based public health model is gaining momentum across healthcare, including initiatives such as newborn genomic screening programs. ​​

A more predictive, preventive approach to medicine can enable more accurate population-level risk assessments and predictions of clinical outcomes. It can also drive more efficient drug development and clinical trial design. Without precise interpretation, even the most advanced omics-based technologies cannot fully realize their clinical potential.

The Limitations Of Current Variant Interpretation Frameworks

Modern clinical genomics excels at identifying variants. Genome-wide sequencing can uncover a significant number of genetic differences in an individual. However, translating these findings into clinically meaningful insights remains a complex and computationally intensive challenge. I’ve found that current variant interpretation frameworks rely heavily on a limited number of reference genomes, incomplete and underrepresented population datasets and computational models constrained by classical processing capabilities.

Variants should be classified according to established criteria. For example, consider the criteria recommended by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology: “‘pathogenic,’ ‘likely pathogenic,’ ‘uncertain significance,’ ‘likely benign,’ and ‘benign’—to describe variants identified in genes that cause Mendelian disorders.”​ The two organizations’ recommendation for variant classification is “based on criteria using typical types of variant evidence (e.g., population data, computational data, functional data, segregation data).”​​​

​Today, variant interpretation continues to face significant clinical gaps. From my observations, existing approaches often fail to fully leverage reference datasets representing diverse human populations and lack integrated use of clinical phenotypes, longitudinal patient outcomes and dynamic biological data layers. These layers include non-coding RNA profiles, risk allele modifiers, epigenomic variation, proteomic profiles and microbiome profiles, alongside environmental, wearable-derived and demographic factors.

This limited contextual integration constrains the accuracy, resolution and clinical utility of variant classification. As a result, a substantial proportion of detected variants, particularly rare and novel findings, are at risk of being classified as variants of uncertain significance, ultimately limiting clinical actionability and leaving both clinicians and patients without definitive answers. Even when a variant is classified as pathogenic or likely pathogenic for a specific disease, uncertainty can remain, as its clinical manifestation may be influenced by incomplete penetrance and variable expressivity. This challenge can be further compounded by the routine filtering and underrepresentation of information from the non-coding genome, including unknown regulatory elements, intronic regions and structurally complex or dark regions that are difficult to resolve with current computational approaches, thereby limiting our understanding of diseases with unknown genetic etiology.​​

The Integration Of Quantum Computing And Artificial Intelligence Can Improve Variant Interpretation

The integration of quantum computing and artificial intelligence introduces a fundamentally new computational paradigm capable of addressing the combinatorial complexity inherent in genomic data. While this technology is still evolving, it has the potential to accelerate research and clinical practice in genomics and precision medicine. Optimizing clinical interpretation of genomic variants detected serves as a critical foundation for developing advanced machine learning (ML) models that can support not only disease diagnosis, treatment optimization and prevention strategies, but also accelerate drug discovery and clinical trial enrollments. ​

Unlike classical systems, which are limited by sequential or constrained parallel processing, quantum systems can evaluate vast multidimensional solution spaces, enabling the simultaneous analysis of large-scale genomic datasets, moving beyond reliance on a single or limited reference genome. ​

When combined with advanced AI models, quantum computing supports the identification of complex, high-order patterns across genetic variation and enables rapid modeling of gene-gene, gene-environment and multi-omic interactions.​

Critically, these capabilities can extend to real-time analyses across expansive datasets encompassing genomics, epigenomics and proteomics derived from diverse populations. This allows for more representative, dynamic and biologically meaningful modeling of human disease. ​

By contrast, from my observations, current genomic models that are driven by artificial intelligence remain limited by simulation-based approaches or limited reference datasets—due to the computational limitations of classical systems. Furthermore, another issue I’ve seen with conventional AI is that it often de-emphasizes outliers and overlooks hidden signals where meaningful biology may exist. Additionally, large language models can incorporate fabricated details in their outputs.

The Limits Of Quantum Computing

However, quantum computing is an emerging technology with important limitations that must be addressed before widespread clinical adoption. For example, quantum systems are sensitive to environmental factors. Processing these sequences requires more stable qubits than are currently available in today’s quantum systems.

Infrastructure and accessibility present additional challenges. Namely, in the future, quantum platforms will have to integrate with existing bioinformatics pipelines.

How Quantum-Enabled AI Can Impact Clinical Decision-Making, Public Health And Patient Privacy

In clinical medicine, speed impacts outcomes. Quantum-enabled AI has the potential to significantly reduce turnaround times by accelerating variant classification and pathogenicity assessment, and by performing large-scale comparative analyses. What currently requires days to obtain meaningful results may be significantly reduced, enabling timely and precise clinical decision-making when it matters most.​

The convergence of quantum computing and AI also has the potential to reshape public health. For instance, with more accurate identification of genetic predispositions, clinicians and patients would be better equipped to anticipate, monitor and manage disease risk. Rather than reacting to disease after its onset, healthcare systems can shift toward early detection, prevention and personalized intervention.​

By enabling earlier diagnosis and more targeted prevention strategies, genomic insights driven by quantum-enabled AI can reduce disease burden, improve outcomes and lower long-term healthcare costs. ​

Additionally, ensuring privacy, security and ethical use of genomic data is essential. Quantum-enabled federated learning frameworks enable large-scale analysis of distributed datasets without requiring the centralized sharing of sensitive patient data, preserving individual privacy while enabling collaboration. These approaches also reduce risks associated with the misuse of genetic information, including potential discrimination. Robust regulatory frameworks and governance must be established for the clinical use of emerging technologies to ensure safety, reliability and accountability in patient care. ​

Quantum computing remains an emerging technology, but I predict that continued advancements will accelerate its integration into genomics and precision medicine. The way I see it, the true promise of quantum AI lies not only in computational power but also in its ability to transform how genetic variation is interpreted to convert complex data into actionable insights, ultimately enabling a more proactive, equitable and effective healthcare system.​​

Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?